Rheumatology

Preventing Pregnancies for Patients on Teratogenic Medications
Preventing Pregnancies for Patients on Teratogenic Medications 1024 575 Emily Siebenmorgen
Teen girl with backpack

In a recent study from Nationwide Children’s Hospital, researchers increased the time between pregnancies for patients on teratogenic medications from an average of 52 days to over 900 days through quality improvement (QI) and behavioral economics. Teratogenic medications such as methotrexate and mycophenolate are often used to treat rheumatic diseases. They can also result in…

Nephritis Identified as High Research Priority Area For Childhood-Onset Lupus
Nephritis Identified as High Research Priority Area For Childhood-Onset Lupus 150 150 Lauren Dembeck

In an effort to establish research priorities in childhood-onset systemic erythematous lupus (cSLE), researchers at Nationwide Children’s Hospital partnered with the Lupus Foundation of America (LFA) and Childhood Arthritis and Rheumatology Research Alliance (CARRA). Their findings are recently published in Pediatric Rheumatology. According to the results of their multidisciplinary prioritization survey of leading rheumatology, dermatology and…

Opening the Door to Adult Medicine
Opening the Door to Adult Medicine 1024 575 Katie Brind'Amour, PhD, MS, CHES

Care transition plans aren’t just for kids with congenital conditions anymore. Could your practice benefit from a proactive transition plan for all patients? In the shift from pediatric to adult care, young patients have the responsibility to adjust to a new life of self-management. But health care providers also play an important role in this…

Subclinical Muscle Involvement May be Missed With Amyopathic Juvenile Dermatomyositis Diagnosis
Subclinical Muscle Involvement May be Missed With Amyopathic Juvenile Dermatomyositis Diagnosis 150 150 Abbie Miller

Study shows that some children diagnosed with amyopathic dermatomyositis have subclinical muscle involvement, highlighting the need for standardized workup and treatment protocols. Juvenile dermatomyositis (JDM) is an autoimmune disease that classically presents in preschool to school aged children with a rash and muscle weakness. In some cases, children may present with the rash, but no muscle…